Look at the Consolidated Statement of Cash Flows for Target on PDF page $40$Consolidated Statements of Operations

$($millions$,$ except per share data$)202120202019$

Sales $ $104,611$ $ $92,400$ $ $77,130$

Other revenue $1,3941,161982$

Total revenue $106,00593,56178,112$

Cost of sales $74,96366,17754,864$

Selling, general and administrative expenses $19,75218,61516,233$

Depreciation and amortization $($exclusive of depreciation included in cost

of sales$)2,3442,2302,357$

Operating income $8,9466,5394,658$

Net interest expense $421977477$

Net other $($income$)/$ expense $(382)16(9)$

Earnings from continuing operations before income taxes $8,9075,5464,190$

Provision for income taxes $1,9611,178921$

Net earnings from continuing operations $6,9464,3683,269$

Discontinued operations, net of tax $12$

Net earnings $ $6,946$ $ $4,368$ $ $3,281$

Basic earnings per share

Continuing operations $ $14\mathrm{.}23$ $ $8\mathrm{.}72$ $ $6\mathrm{.}39$

Discontinued operations $0\mathrm{.}02$

Net earnings per share $ $14\mathrm{.}23$ $ $8\mathrm{.}72$ $ $6\mathrm{.}42$

Diluted earnings per share

Continuing operations $ $14\mathrm{.}10$ $ $8\mathrm{.}64$ $ $6\mathrm{.}34$

Discontinued operations $0\mathrm{.}02$

Net earnings per share $ $14\mathrm{.}10$ $ $8\mathrm{.}64$ $ $6\mathrm{.}36$

Weighted average common shares outstanding

Basic $488\mathrm{.}1500\mathrm{.}6510\mathrm{.}9$

Diluted $492\mathrm{.}7505\mathrm{.}4515\mathrm{.}6$

Antidilutive shares $$

Note: Per share amounts may not foot due to rounding.

See accompanying Notes to Consolidated Financial Statements.

FINANCIAL STATEMENTS Table of Contents

Index to Financial Statements

TARGET CORPORATION $2021$ Form $10-$K $38$

Consolidated Statements of Comprehensive Income

$($millions$)202120202019$

Net earnings $ $6,946$ $ $4,368$ $ $3,281$

Other comprehensive income $/($loss$),$ net of tax

Pension benefit liabilities $152102(65)$

Currency translation adjustment and cash flow hedges $51102$

Other comprehensive income $/($loss$)203112(63)$

Comprehensive income $ $7,149$ $ $4,480$ $ $3,218$

See accompanying Notes to Consolidated Financial Statements.

FINANCIAL STATEMENTS Table of Contents

Index to Financial Statements

$39$ TARGET CORPORATION $2021$ Form $10-$K

Consolidated Statements of Financial Position

$($millions$,$ except footnotes$)$

January $29,$

$2022$

January $30,$

$2021$

Assets

Cash and cash equivalents $ $5,911$ $ $8,511$

Inventory $13,90210,653$

Other current assets $1,7601,592$

Total current assets $21,57320,756$

Property and equipment

Land $6,1646,141$

Buildings and improvements $32,98531,557$

Fixtures and equipment $6,4075,914$

Computer hardware and software $2,5052,765$

Construction$-$in$-$progress $1,257780$

Accumulated depreciation $(21,137)(20,278)$

Property and equipment, net $28,18126,879$

Operating lease assets $2,5562,227$

Other noncurrent assets $1,5011,386$

Total assets $ $53,811$ $ $51,248$

Liabilities and shareholders' investment

Accounts payable $ $15,478$ $ $12,859$

Accrued and other current liabilities $6,0986,122$

Current portion of long$-$term debt and other borrowings $1711,144$

Total current liabilities $21,74720,125$

Long$-$term debt and other borrowings $13,54911,536$

Noncurrent operating lease liabilities $2,4932,218$

Deferred income taxes $1,566990$

Other noncurrent liabilities $1,6291,939$

Total noncurrent liabilities $19,23716,683$

Shareholders' investment

Common stock $3942$

Additional paid$-$in capital $6,4216,329$

Retained earnings $6,9208,825$

Accumulated other comprehensive loss $(553)(756)$

Total shareholders' investment $12,82714,440$

Total liabilities and shareholders' investment $ $53,811$ $ $51,248$

Common Stock Authorized $6,000,000,000$ shares, $$0\mathrm{.}0833$ par value; $471,274,073$ shares issued and outstanding

as of January $29,2022$; $500,877,129$ shares issued and outstanding as of January $30,2021.$

Preferred Stock Authorized $5,000,000$ shares, $$0\mathrm{.}01$ par value; no shares were issued or outstanding during any

period presented.

See accompanying Notes to Consolidated Financial Statements.

FINANCIAL STATEMENTS Table of Contents

Index to Financial Statements

TARGET CORPORATION $2021$ Form $10-$K $40$

Consolidated Statements of Cash Flows

$($millions$)202120202019$

Operating activities

Net earnings $ $6,946$ $ $4,368$ $ $3,281$

Earnings from discontinued operations, net of tax $12$

Net earnings from continuing operations $6,9464,3683,269$

Adjustments to reconcile net earnings to cash provided by operations:

Depreciation and amortization $2,6422,4852,604$

Share$-$based compensation expense $228200147$

Deferred income taxes $522(184)178$

Gain on Dermstore sale $(335)$

Loss on debt extinguishment $51210$

Noncash losses $/($gains$)$ and other, net $678629$

Changes in operating accounts:

Inventory $(3,249)(1,661)505$

Other assets $(78)(137)18$

Accounts payable $2,6282,925140$

Accrued and other liabilities $(746)1,931199$

Cash provided by operating activities$$continuing operations $8,62510,5257,099$

Cash provided by operating activities$$discontinued operations $18$

Cash provided by operating ac$.$ What was the adjustment for Depreciation and amortization for fiscal year $2020?$